amifostine anhydrous has been researched along with Graft-Versus-Host Disease in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thompson, JS | 1 |
| Asmis, R | 1 |
| Chu, Y | 1 |
| Glass, J | 1 |
| Nelson, B | 1 |
| Brown, SA | 1 |
1 other study available for amifostine anhydrous and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Amifostine prior to lethal irradiation prevents allogeneic bone marrow engraftment in mice.
Topics: Amifostine; Animals; Bone Marrow Transplantation; Disease Models, Animal; Graft Rejection; Graft Sur | 2008 |